KFI
LFCR icon

Key Financial Inc’s Lifecore Biomedical LFCR Stock Holding History

Key Financial Inc’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,120
Closed -$4.17K – 1409
2026
Q1 		$4.17K Hold
1,120
– – ﹤0.01% 1070
2025
Q4 		$9.16K Hold
1,120
– – ﹤0.01% 907
2025
Q3 		$8.03K Hold
1,120
– – ﹤0.01% 938
2025
Q2 		$9.09K Buy
+1,120
New +$7.55K ﹤0.01% 878
2024
Q2 		– Sell
-1,120
Closed -$5.95K – 1363
2024
Q1 		$5.95K Hold
1,120
– – ﹤0.01% 894
2023
Q4 		$6.93K Hold
1,120
– – ﹤0.01% 832
2023
Q3 		$8.45K Hold
1,120
– – ﹤0.01% 760
2023
Q2 		$10.8K Hold
1,120
– – ﹤0.01% 699
2023
Q1 		$4.23K Sell
1,120
-2,145
-66% -$12K ﹤0.01% 843
2022
Q4 		$29K Hold
3,265
– – 0.01% 438
2022
Q3 		$29K Hold
3,265
– – 0.01% 442
2022
Q2 		$33K Hold
3,265
– – 0.02% 427
2022
Q1 		$38K Hold
3,265
– – 0.02% 395
2021
Q4 		$36K Hold
3,265
– – 0.02% 394
2021
Q3 		$30K Hold
3,265
– – 0.02% 409
2021
Q2 		$36K Buy
+3,265
New +$37.6K 0.02% 393

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Key Financial Inc's LFCR Position: Q2 2026 in Review

Key Financial Inc sold out of Lifecore Biomedical (LFCR) in Q2 2026, closing a stake of 1,120 shares — an estimated $4.17K sold.

Key Financial Inc first reported a position in LFCR in Q2 2021 and held it in 16 quarters. The position peaked at $38K in Q1 2022. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Key Financial Inc reported no remaining Lifecore Biomedical position as of Q2 2026 after selling out during the quarter.
  • Key Financial Inc sold 1,120 Lifecore Biomedical shares in Q2 2026, an estimated $4.17K.
  • Key Financial Inc first reported a position in Lifecore Biomedical in Q2 2021 and held it in 16 quarters.
  • Key Financial Inc's Lifecore Biomedical position peaked at $38K in Q1 2022.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.